Amgen Inc.
AMGN Healthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.
Follow AMGN
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
2,375.00 | 1,819.00 | 1,333.00 | 3,216.00 |
+8 more quarters Free account |
Depreciation & Amortization |
1,112.00 | 1,116.00 | 1,132.00 | 1,707.00 | |
Non Cash Items (Other) |
107.00 | (25.00) | 1,004.00 | (1,902.00) | |
Accounts Receivable Change |
(1,093.00) | 413.00 | (1,075.00) | 222.00 | |
Change in inventories |
(31.00) | 18.00 | 119.00 | 240.00 | |
Accounts Payable Change |
(70.00) | 571.00 | (484.00) | (174.00) | |
Change in payables and accrued liability |
1,986.00 | (1,873.00) | 441.00 | 974.00 | |
Income tax paid |
(54.00) | 142.00 | (290.00) | 684.00 | |
Change in other assets and liabilities |
(330.00) | 8.00 | (577.00) | (283.00) | |
Operating Cash Flow |
4,002.00 | 2,189.00 | 1,603.00 | 4,684.00 | |
Capital expenditures |
(513.00) | (712.00) | (642.00) | (436.00) | |
Net Aquisitions |
— | — | (53.00) | — | |
Other investing activities |
(56.00) | (4.00) | 2.00 | 22.00 | |
Investing cash flow |
(569.00) | (716.00) | (693.00) | (414.00) | |
Repayment/Issuance of Debt (Net) |
0.00 | 3,131.00 | 0.00 | (1,500.00) | |
Dividends Paid (Total) |
(1,362.00) | (1,358.00) | (1,283.00) | (1,282.00) | |
Other financial activities |
(120.00) | (337.00) | 57.00 | (71.00) | |
Financing cash flow |
(1,482.00) | 1,436.00 | (1,226.00) | (2,853.00) | |
Change in Cash |
1,951.00 | 2,909.00 | (316.00) | 1,417.00 | |
Beginning Cash |
0.00 | 9,129.00 | 0.00 | 0.00 | |
Ending Cash |
1,951.00 | 12,038.00 | (316.00) | 1,417.00 | |
Stock Based Compensation |
165.00 | 75.00 | 125.00 | 127.00 | |
Dividends Paid (Common) |
(1,362.00) | (1,358.00) | (1,283.00) | (1,282.00) | |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
408.00 | (721.00) | (1,866.00) | 1,663.00 |